Your browser doesn't support javascript.
loading
Lamotrigine versus inert placebo in the treatment of borderline personality disorder: study protocol for a randomized controlled trial and economic evaluation.
Crawford, Mike J; Sanatinia, Rahil; Barrett, Barbara; Byford, Sarah; Cunningham, Gillian; Gakhal, Kavi; Lawrence-Smith, Geof; Leeson, Verity; Lemonsky, Fenella; Lykomitrou, Georgia; Montgomery, Alan; Morriss, Richard; Paton, Carol; Tan, Wei; Tyrer, Peter; Reilly, Joseph G.
Afiliação
  • Crawford MJ; Centre for Mental Health, Imperial College London, Du Cane Road, London, W12 ONN, UK. m.crawford@imperial.ac.uk.
  • Sanatinia R; Centre for Mental Health, Imperial College London, Du Cane Road, London, W12 ONN, UK. r.sanatinia@imperial.ac.uk.
  • Barrett B; King's Health Economics, King's College London, De Crespigny Park, London, SE5 8AF, UK. barbara.barrett@kcl.ac.uk.
  • Byford S; King's Health Economics, King's College London, De Crespigny Park, London, SE5 8AF, UK. s.byford@kcl.ac.uk.
  • Cunningham G; School of Medicine, Pharmacy and Health, Durham University, Stockton Road, Durham, DH1 3LE, UK. gillian.cunningham1@nhs.net.
  • Gakhal K; Centre for Mental Health, Imperial College London, Du Cane Road, London, W12 ONN, UK. k.gakhal@imperial.ac.uk.
  • Lawrence-Smith G; Oxleas NHS Foundation Trust, Pinewood Place, Dartford, DA2 7WG, UK. geoff.lawrence-smith@oxleas.nhs.uk.
  • Leeson V; Centre for Mental Health, Imperial College London, Du Cane Road, London, W12 ONN, UK. v.leeson@imperial.ac.uk.
  • Lemonsky F; Centre for Mental Health, Imperial College London, Du Cane Road, London, W12 ONN, UK. flemonsky@sky.com.
  • Lykomitrou G; Faculty of Medicine & Health Sciences, University of Nottingham, Queen's Medical Centre, Nottingham, NG7 2UH, UK. georgia.lykomitrou@nottshc.nhs.uk.
  • Montgomery A; Faculty of Medicine & Health Sciences, University of Nottingham, Queen's Medical Centre, Nottingham, NG7 2UH, UK. alan.montgomery@nottingham.ac.uk.
  • Morriss R; Faculty of Medicine & Health Sciences, University of Nottingham, Queen's Medical Centre, Nottingham, NG7 2UH, UK. richard.morriss@nottingham.ac.uk.
  • Paton C; Oxleas NHS Foundation Trust, Pinewood Place, Dartford, DA2 7WG, UK. c.paton@imperial.ac.uk.
  • Tan W; Faculty of Medicine & Health Sciences, University of Nottingham, Queen's Medical Centre, Nottingham, NG7 2UH, UK. wei.tan@nottingham.ac.uk.
  • Tyrer P; Centre for Mental Health, Imperial College London, Du Cane Road, London, W12 ONN, UK. p.tyrer@imperial.ac.uk.
  • Reilly JG; School of Medicine, Pharmacy and Health, Durham University, Stockton Road, Durham, DH1 3LE, UK. j.g.reilly@durham.ac.uk.
Trials ; 16: 308, 2015 Jul 18.
Article em En | MEDLINE | ID: mdl-26187496
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Antipsicóticos / Triazinas / Transtorno da Personalidade Borderline Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Health_economic_evaluation Aspecto: Patient_preference Limite: Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Trials Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Antipsicóticos / Triazinas / Transtorno da Personalidade Borderline Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Health_economic_evaluation Aspecto: Patient_preference Limite: Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Trials Ano de publicação: 2015 Tipo de documento: Article